In this episode of The Upgrade podcast we discuss the recent large LBO of healthcare sector company Medline. Topics include our views on the company’s business, financial and debt recovery prospects, as well as how Medline compares to existing CLO collateral. Guests include analysts from S&P’s corporate healthcare, recovery, and CLO teams.
Our aim is to provide market participants with further advanced analytical insight into Corporate Credits, CLOs and Leveraged Finance deals, with S&P Global Ratings regular podcast, based on key features we’re seeing in corporate credits and sectors that CLOs are exposed to. For more Leveraged Finance and CLOs Insights visit Leveraged Finance & CLOs Essentials